Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-30 00:34:42 - browse：36

Adobe

The Food and Drug Administration has cleared Otsuka Pharmaceutical’s digital treatment for major depressive disorder, offering a new option for millions of people who struggle with the stubborn mental health condition.

Called Rejoyn, the smartphone-based treatment for major depressive disorder symptoms was developed with digital health company Click Therapeutics, and it is intended for use by prescription alongside antidepressants. The six-week program delivers a novel “cognitive-emotional training” technique, in which people are asked to identify and recall faces showing different emotions. Researchers hypothesize that the technique targets the brain’s dorsolateral prefrontal cortex and the amygdala and may “enhance cognitive control over emotional information processing.” Patients also receive cognitive behavioral therapy.

Rejoyn has been in development since 2018, and Otsuka is the first drug company to receive FDA clearance for a digital treatment for a mental health condition. But that landmark comes amid many questions about whether such digital therapeutics deliver their advertised results — and whether they can gain traction with clinicians, insurers, and patients. Prescription digital therapeutics have yet to see a blockbuster success, and several companies have gone out of business trying to create one.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： First Opinion Podcast: What happens when kids become caregivers?

WSS

Adam's Biotech Scorecard: Do Sarepta's exon

Alabama frozen embryo ruling has major implications for IVF clinics

Akili, maker of video game for ADHD, to be acquired for 34 million

Why palliative psychiatry is worth discussing

A solution to the after

Adam's Biotech Scorecard: Do Sarepta's exon

focus

Wikipedia

explore

In age of alternative facts, a scholarly course on calling out crap

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Tori Bowie and the unacceptable rates of Black maternal death

What will save rural psychiatry services? Higher Medicaid payments

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Alabama frozen embryo ruling has major implications for IVF clinics

Cancer drug shortages should be causing more outrage

R1 RCM gets $5.8 billion buyout offer from private equity firm

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Adam's Biotech Scorecard: Do Sarepta's exon

hotspot

What will save rural psychiatry services? Higher Medicaid payments

Scientists successfully use ultrasound imaging to map brain activity

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Heat waves linked to early deliveries, preterm births in new study

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

PBM reform efforts get punted in Congress

Wikipedia

Wikipedia

hotspot

knowledge